Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?, Nat Clin Pract Nephrol, vol.3, issue.12, pp.679-687, 2007. ,
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, issue.4, pp.554-562, 2012. ,
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, issue.10, pp.1844-1859, 2010. ,
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation, Am J Transplant, vol.12, issue.12, pp.3337-3354, 2012. ,
Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background, Clin J Am Soc Nephrol, vol.1, issue.1, pp.88-99, 2006. ,
Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome, Am J Transplant, vol.13, issue.3, pp.663-675, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00945715
Atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, issue.17, pp.1676-1687, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01793663
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, issue.11, pp.643-657, 2012. ,
Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS, Semin Thromb Hemost, vol.36, issue.6, pp.633-640, 2010. ,
Eculizumab for paroxysmal nocturnal haemoglobinuria, Lancet, vol.373, issue.9665, pp.759-767, 2009. ,
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.368, issue.23, pp.2169-2181, 2013. ,
Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations, J Am Soc Nephrol, vol.21, issue.5, pp.859-867, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00512540
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N Engl J Med, vol.339, issue.22, pp.1578-1584, 1998. ,
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany, N Engl J Med, vol.365, pp.1771-1780, 2011. ,
VEGF inhibition and renal thrombotic microangiopathy, N Engl J Med, vol.358, issue.11, pp.1129-1136, 2008. ,
DOI : 10.1056/nejmoa0707330
Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases, Medicine, vol.91, issue.4, pp.195-205, 2012. ,
Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a frequent and severe consequence of active disease, Rheumatology, vol.45, issue.9, pp.1170-1171, 2006. ,
Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome, BMC Nephrol, vol.14, p.3, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00780835